| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Mordechai Elgrabli CEO | ASX Exchange | AU0000134173 ISIN |
| Il Country | 427 Employees | - Last Dividend | 28 Sep 2023 Last Split | - IPO Date |
Rekah Pharmaceutical Industry Ltd. is an established entity in the pharmaceutical sector based in Holon, Israel, with operations focused on the manufacture, marketing, sale, and distribution of a broad array of healthcare products. Since its inception in 1941, the company has grown to become a key player in the Israeli pharmaceutical industry, offering a wide range of prescription and over-the-counter (OTC) medications, dermo-cosmetic products, vitamins, and nutritional supplements. Its commitment to healthcare is reflected in its substantial portfolio of approximately 280 drugs catering to various medical needs.
Rekah Pharmaceutical Industry Ltd. offers a diverse range of products across multiple healthcare categories, ensuring comprehensive coverage of numerous medical conditions and health maintenance needs. These include: